Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
Gliomas, the most prevalent primary brain tumors, exhibit a poor five-year survival rate despite advances in various treatments, necessitating further studies to understand tumor progression and develop new therapies, particularly targeting EphA2, which is implicated in vasculogenic mimicry and glio...
Saved in:
| Main Authors: | Huangde Fu, Shengtian Wu, Hechun Shen, Kai Luo, Zhongxiang Huang, Nankun Lu, Yaolin Li, Qian Lan, Yishun Xian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402500475X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK
by: Nozomi Hirai, et al.
Published: (2025-05-01) -
Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01) -
The balance between deception and adaptation: vasculogenic mimicry as a tumor survival strategy
by: E. A. Prosekina, et al.
Published: (2025-04-01) -
EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway [Retraction]
by: Zhang R, et al.
Published: (2025-07-01) -
Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis
by: Eun Hye Lee, et al.
Published: (2025-01-01)